Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$72.62 - $150.62 $2.76 Million - $5.72 Million
-38,000 Reduced 94.06%
2,400 $361,000
Q1 2024

May 15, 2024

SELL
$70.86 - $89.93 $1.03 Million - $1.31 Million
-14,600 Reduced 26.55%
40,400 $2.99 Million
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $1.65 Million - $3.65 Million
45,000 Added 450.0%
55,000 $4.34 Million
Q2 2023

Aug 14, 2023

BUY
$66.23 - $88.73 $662,300 - $887,300
10,000 New
10,000 $839,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $5.25B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.